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Abstract Cell culture studies have given much valuable infor-
mation about mechanisms of metabolism and signal transduc-
tion and of regulation of gene expression, proliferation, senes-
cence, and death. However, cells in culture may behave
di¡erently from cells in vivo in many ways. One of these is
that cell culture imposes a state of oxidative stress on cells. I
argue that cells that survive and grow in culture might use ROS-
dependent signal transduction pathways that rarely or never
operate in vivo. A further problem is that cell culture media
can catalyse the oxidation of compounds added to them, result-
ing in apparent cellular e¡ects that are in fact due to oxidation
products such as ROS. Such artefacts may have a¡ected many
studies on the e¡ects of ascorbate, thiols, £avonoids and other
polyphenolic compounds on cells in culture.
# 2003 Federation of European Biochemical Societies. Pub-
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1. Introduction
Cell culture is almost-universally used in laboratories
worldwide to examine metabolic pathways and to elucidate
the mechanisms involved in signal transduction, regulation
of gene expression, cell proliferation and cell death. It has
provided a huge amount of valuable information, including
helping to elucidate metabolic pathways and the roles of MAP
kinases, NFUB, AP-1, nitric oxide and caspases in vivo. How-
ever, cells in culture may be di¡erent from those in vivo in
many ways. To take my own ¢eld of interest [1] as an exam-
ple, oxygen free radicals [including superoxide (Oc32 ) and hy-
droxyl (OHc) radicals] and other reactive oxygen species
(ROS) such as hydrogen peroxide (H2O2) have been shown
to mediate the growth-promoting, metabolic, or cytostatic ef-
fects of a wide range of growth factors and cytokines on
cultured cells, ranging from TGFL to angiotensin II, VEGF,
and insulin [2^12]. Yet here there is very limited evidence that
these e¡ects mediated by ROS are important in vivo [13^15].
It is well-known that many cellular events are regulated by
changes in redox status, often involving the glutathione and
thioredoxin systems [5,10,15,16]. ROS can alter the redox sta-
tus of the cell and thus ‘send a signal’, but this does not mean
that ROS are necessarily the mechanism by which such signals
are sent in vivo [13^15]. A huge range of agents, from cyto-
toxic drugs to diet-derived antioxidants show remarkable ef-
fects when added to cells in culture, yet many are a disap-
pointment when tried in vivo. Metabolism and bioavailability
are obvious explanations for this discrepancy. I suggest here
however that cell culture imposes an inappropriate oxidative
stress that may, under certain circumstances, lead to mislead-
ing conclusions.
Many cell culture studies are done with malignant cell lines,
because such cells are robust and grow and divide easily in
culture. This makes sense when looking for chemotherapeutic
agents, but less sense when trying to elucidate pathways rele-
vant to normal cells. An alternative is primary culture, where
cells are harvested from a tissue and plated. Some of them will
survive, but many die because of the stress of the isolation
procedure and the ‘foreign environment’ of the culture con-
ditions. Values of 1^10% have been quoted for the number of
originally harvested cells that survive [17]. The words ‘culture
shock’ have been used to describe this phenomenon [17,18].
To take examples, isolated of rat hepatocytes causes activa-
tion of nitric oxide synthase within them, generating toxic
levels of NO that alter cell metabolism [19]. Cell trypsinisation
processes can cause a decrease in levels of cellular reduced
glutathione, GSH [20,21]. The cells which do survive ‘culture
shock’ appear to be those that have adapted rapidly, with
multiple changes in gene expression, metabolic activity and
the levels of enzymes [21^23]. Some enzyme levels are upregu-
lated, other swiftly downregulated [23]. Thus only a fraction,
and probably an unrepresentative fraction, of the initially
plated cells survives. As an example, p53 is not expressed in
14-day mouse embryos but in culture of ¢broblasts from
them, the cells that survived were those that had begun to
express it [24].
2. ‘Culture shock’ involves oxidative stress
‘Culture shock’ a¡ects cells in many ways, but one of them
is to impose oxidative stress. The term ‘oxidative stress’ refers
to a serious imbalance between the levels of ROS in a cell and
its antioxidant defences in favour of the former [1,25]. Cell
culture causes oxidative stress for two reasons: (a) it leads to
more ROS generation, and (b) it can impair cellular antioxi-
dant defences.
2.1. More ROS generation
Most cells in vivo in animals are exposed to low O2 con-
centrations, in the range of 1^10 mm Hg, although there are
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exceptions (including skin epidermis, cornea and respiratory
tract lining cells) [1,26]. Cell culture is commonly performed
under 95% air/5% CO2, approximately 150 mm Hg O2 ten-
sion. The rates of production of ROS by cellular enzyme
systems and by ‘leakage’ of electrons from electron transport
chains are O2-limited at normal cellular levels and will thus
increase if O2 level is raised [1,26^28]. Therefore more ROS
will be produced in cells in culture. Cellular oxidative stress
can cause senescence, cell death, or adaptation [1]. Cells that
fail to adapt may not divide or may die [1,13,29^34] and only
the cells that adapt, probably a small proportion of the total,
will survive. Even then, the culture stress may a¡ect their
properties. An example of this is revealed by attempts to
determine the ‘Hay£ick limit’, the number of times that cells
can divide in culture before they undergo senescence [17]. For
human ¢broblasts a value of 40^50 doublings was originally
suggested. Recent work by Shay et al. [17] has shown that if
cells are grown at low O2, many more doublings are possible.
The original Hay£ick limits were artefactually low, due in part
to culture-related oxidative stress causing accelerated telomere
shortening [17,35]. Others of the many aspects in which cell
culture does not replicate conditions in vivo also a¡ect the
apparent Hay£ick limit [36].
Cellular adaptation to the oxidative stress of ‘culture shock’
in the minority of cells that survive could, in principle, involve
increases in antioxidant defences, downregulating levels of
ROS-generating enzymes, adapting electron transport chains
to become less leaky and so produce lower amounts of Oc32 , or
altering cellular targets of oxidative damage to become more
resistant to damage by ROS [1,34,37]. Adaptation can be
associated with O2-dependent increased mutation frequency
or a hypermutable state [38^40]. A further step might then
occur. It is possible that a cell that has adapted to oxidative
stress can further adapt to use ROS. For example, some ma-
lignant cells in culture appear to use ROS to promote prolif-
eration and suppress apoptosis [41,42]. Non-malignant cells
may evolve comparable strategies ; because more ROS are
produced under the pro-oxidant environment of cell culture,
cells may activate ROS-dependent signal transduction path-
ways that rarely, if ever, operate in vivo in healthy tissues. It
is thus possible that some of the ROS-dependent pathways
that various cells use to respond to cytokines and other mol-
ecules in culture [2^11] are not physiological. More work in
whole animals is required [13]. For example, overexpression of
antioxidant defence enzymes in transgenic animals would be
expected to lower ROS and interfere with ROS-dependent
signal transduction pathways, but few studies of this type
have been reported.
2.2. Fewer antioxidants
Adaptation of cells by upregulation of antioxidant defence
systems is also hampered in the ‘culture shock’ regime. Cell
culture media are frequently de¢cient in antioxidants, espe-
cially tocopherols and ascorbate. Vitamin E is rarely added
because it is insoluble in water and vitamin C because it is
unstable (section 3 below). It follows that cells are deprived of
important antioxidants, a situation which can lead to over-
interpretations of the bene¢cial e¡ects of added antioxidants
[43^45]. Antioxidants may appear to have bene¢cial e¡ects
when added to cultured cells, but this is because a de¢ciency
is being corrected rather than being a real bene¢cial e¡ect of
‘extra antioxidants’. Indeed, this may help to explain why
trials of antioxidant supplementation in humans have given
only limited evidence of bene¢t, although of course many
other factors are important in explaining the results of such
trials (reviewed in [29]). Culture media can be de¢cient in
selenium [43,46], to an extent which may decrease (or at least
prevent oxidative stress-triggered rises in) the activities of anti-
Table 1
Examples of artifacts probably caused by oxidation of compounds added to cell culture media
Observation Comment Reference
Induction of apoptosis by ascorbate in HL-60 cells Entirely due to generation of H2O2 by ascorbate
oxidation in cell culture media
[52]
Induction of apoptosis by green tea in PC12 cells Entirely due to generation of H2O2 by oxidation of
tea components in cell culture media
Halliwell and Long submitted
Induction of cell death by L-DOPA and dopamine
in PCl2 and M14 cells
Entirely due to H2O2, quinones, and semiquinones
generated by oxidation of L-DOPA and dopamine in
the culture medium
[70]
Toxicity of apple phenolics to cancer cells Entirely due to oxidation to produce H2O2 in the
culture medium
[62]
Cell death induced by gallic acid Entirely due to oxidation of gallic acid to produce
H2O2 in culture medium
[60]
Addition of grape seed extract to CaCo-2 cell
culture medium generates H2O2 due to oxidation of
phenolics in the medium
^ [63]
E¡ects of polyphenols on c-jun phosphorylation in
bronchial epithelial cell lines
Shown to involve H2O2. Although H2O2 was not
speci¢cally identi¢ed as coming from the culture
medium, this seems likely
[64]
Epigallocatechin gallate induces apoptosis in human
oral cell lines
Due to production of H2O2 in the culture medium [65]
Toxicity of myricetin to Chinese hamster lung
¢broblast V79 cells
Due to H2O2 production. Although H2O2 was not
speci¢cally identi¢ed as coming from the culture
medium, this seems likely
[66]
Cell culture media found to generate ROS as
detected by spin traps and £uorescent dyes
^ [67]
Ascorbate observed to inhibit cell proliferation and
¢bronectin synthesis in human skin ¢broblasts
Inhibition by catalase, suggests may be due to H2O2
generation in the culture medium
[52,68]
Inhibition of L-catenin/Tcf activity by tea and
epigallocatechin-3-gallate
H2O2 generated in the culture medium, but minor
contributor to the e¡ects observed
[69]
FEBS 27106 25-3-03
B. Halliwell/FEBS Letters 540 (2003) 3^64
oxidant systems that are selenium-dependent. These include
thioredoxin reductase [16] and the glutathione peroxidase
family [46].
3. Cell culture media can be pro-oxidant
Cells require transition metal ions, especially iron and cop-
per, in order to grow. Unless specially puri¢ed, all laboratory
solutions and cell culture media are contaminated with such
ions [1,47^49]. In some media, inorganic metal salts are
added. Thus Dulbecco’s modi¢ed Eagle’s medium contains
added iron(III) nitrate, Fe(NO3)3. In other media, iron is
supplied in transferrin-bound form, and calf serum will con-
tain some transferrin. Whereas transferrin-bound iron will not
normally catalyse free radical reactions [50], ‘free’ iron ions
are powerfully pro-oxidant, as are copper and many other
transition metal ions [1,51].
Ascorbate, £avonoids, many other polyphenolic com-
pounds, and thiols are unstable in commonly used cell culture
media, undergoing rapid oxidation to generate H2O2 and oth-
er ROS [52^55]. We have proposed that many of the apparent
e¡ects of these molecules on cells in culture are artefacts due
to oxidation in the medium. Examples to illustrate this are
accumulating rapidly (Table 1). Indeed, the problem may be
more widespread. Many substances, including agents used as
allegedly speci¢c inhibitors of signal transduction pathways
and metabolic pathways, are polyphenolic compounds, and
thus likely to be highly oxidisable in cell culture media and
prone to generate artefacts if added at high levels (Table 1).
On the basis of their structure, examples that may be worthy
of investigation include isoproterenol, baicalein, rottlerin, rad-
icicol and the tyrphostin family. Yet another mechanism of
pro-oxidant e¡ects is photochemical. If light intensity is su⁄-
ciently high, ribo£avin in culture media can cause photochem-
ical ROS formation [56,57].
A mainstay of most culture media is foetal calf serum.
Serum or plasma contain some antioxidant enzymes, includ-
ing low levels of catalase, superoxide dismutase, and gluta-
thione peroxidase [58]. Heat treatment, freezing or prolonged
storage of serum will inactivate catalase [1]. Breakdown of
ceruloplasmin in stored serum proceeds rapidly and releases
copper ions [51]. Indeed, leakage of catalase from cells in
culture can raise medium levels in some cases, and a human
T-cell line was able to grow in culture at high, but not low cell
densities for this reason [59]. A ‘protective factor’ isolated
from medium previously used to grow hepatocytes was able
to protect other cells against the cytotoxicity of gallic acid;
the factor was identi¢ed as catalase (Table 1) [60]. Extracel-
lular superoxide dismutase may also be secreted into medium
by some cell types [61]. Catalase in the medium can protect
against H2O2 generated both intracellularly and extracellu-
larly, since H2O2 readily crosses cell membranes and so exter-
nal catalase can ‘drain’ H2O2 out of the cell [1]. The amount
and previous treatment of any foetal calf serum present will
thus be another variable to consider in cell culture.
4. Conclusion
It is widely realised among experts that cells that survive
and grow in culture are not always representative of cells in
vivo, in terms of metabolism, gene expression, and enzyme
levels and that there is a need for caution in extrapolating
data obtained in cell culture to the in vivo situation. Less
widely realised is the extent of the oxidative stress that can
be caused by the cell culture process. Thus ROS-dependent
signal transduction pathways identi¢ed in cultured cells need
to be validated in knockout or transgenic animals. Similarly,
in studies of cellular e¡ects of autoxidisable biomolecules or
extracts containing them, it must be realized that ROS pro-
duction can occur by chemical reactions in the culture media.
The stability of such compounds in the culture medium, and
their propensity to produce ROS and other oxidation prod-
ucts, must be checked before beginning cell studies. Depend-
ing on the cell type and the amount of ROS produced, these
species might exert toxic e¡ects. This explains many (Table 1)
but not all [69] of the previously reported cellular e¡ects of
thiols, ascorbate, and phenols. The resistance of cells to dam-
age by ROS varies widely, depending on the extent to which
the cell has adapted to the oxidative stress of the cell culture
milieu. Low levels of H2O2 can have the paradoxical e¡ect of
accelerating proliferation in some cell types [5,10]. Similarly,
beware of interpreting what appears to be cellular senescence
in cultured cells ; rarely are culture conditions adequate to
permit cells to reach true replicative senescence [17,36].
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